Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to α2- macroglobulin

Clinical Chemistry

Volumn 51, Issue 1, 2005, Pages 84-92

  Baumgart, Yvonne ^a   Otto, Andreas ^a   Schäfer, Angelika ^a   Usbeck, Elke ^a   Cott, Christiane ^a   Schott, Astrid ^a   Tornack, Maria ^a   Wenzel, Anett ^a   Mossie, Andualem ^a   Birkenmeier, Gerd ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNOASSAY; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHAGE DISPLAY; PROSTATE CANCER; PROSTATE HYPERTROPHY; SCREENING; WESTERN BLOTTING;

ALPHA-MACROGLOBULINS; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; IMMUNOASSAY; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; PEPTIDE LIBRARY; PROSTATE-SPECIFIC ANTIGEN; PROTEIN BINDING;

EID: 19944369379     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.039636     Document Type: Article

References (25)

1. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha1-antichymotrypsin. Clin Chem 1991;37:1618-25.
2. 1- antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51: 222-6.
3. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular proteinase inhibitors. Eur J Biochem 1990;194:755-63.
4. 2-macroglobulin. Clin Chem 1998;44:2471-9.
5. Yu H, Diamandis EP. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 1993;39:2108-14.
6. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. A prospective multicenter clinical trial. JAMA 1998;279: 542-7.
7. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76: 1899-903.
8. Otto A, Bär J, Birkenmeier G. Prostate-specific antigen forms complexes with human α2-macroglobulin and binds to the α2-macroglobulin receptor/LDL receptor-related protein. J Urol 1998; 159:297-303.
9. Zor T, Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem 1996;236:302-8.
10. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7.
11. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immunol 2000;1:151-5.
12. 2- macroglobulin deficiency in association with cancer metastasis. Nihon Rinsho Meneki Gakkai Kaishi 1997;20:30-43.
13. Kanoh Y, Ohtani N, Mashiko T, Ohtani S, Nishikawa T, Egawa S, et al. Levels of α2 macroglobulin can predict bone metastases in prostate cancer. Anticancer Res 2001;21:551-6.
14. Middaugh CR, Steadman BL, Schurtenberger P, Lee DC, Chlebowski JF. Changes in structure of α2-macroglobulin upon reaction with trypsin as assessed by light scattering and differential scanning calorimetry. Biochim Biophys Acta 993;1161:328-32.
15. Gonias SL, Allietta MM, Pizzo SV, Castellino FJ, Tillack TW. Electron microscopic identification of exposed plasmin epitopes in α2- macroglobulin-plasmin complex using monoclonal antibody-colloidal gold adducts. J Biol Chem 1988;5:10903-6.
16. Corey E, Wegner S, Stray J, Corey M, Arfman E, Lange P, Vessella R. Characterisation of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays. Int J Cancer 1997;71:1019-28.
17. Michel S, Deleage G, Charrier J, Passagot J, Battail-Poirot N, Sibai G, et al. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling. Clin Chem 1999;45:638-50.
18. Leinonen J, Wu P, Stenman UH. Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries. Clin Chem 2002;48:2208-16.
19. Corey E, Wegner SK, Corey MJ, Vessella RL. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies. Clin Chem 1997;43:575-84.
20. Piironen T, Villoutreix BO, Becker C, Hollingsworth K, Vihinen M, Bridon D, et al. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Protein Sci 1998;7:259-69.
21. Birkenmeier G, Stigbrand T. Production of conformation-specific monoclonal antibodies against α2 macroglobulin and their use for quantitation of total and transformed α2 macroglobulin in human blood. Immunol Methods 1993;162:59-67.
22. Stenman UH, Paus E, Allard WJ, Andersson I, Andres C, Barnett TR et al. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen. Tumour Biol 1999;20:1-12.
23. Nilsson O, Andersson I, Peter A, Karlsson B. Characterization of antibodies to prostate-specific antigen. Tumour Biol 999;1:43-51.
24. Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 1989; 264:11539-42.
25. Villoutreix BO, Getzoff ED, Griffin JH. A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci 1994;3:2033-44.